This study investigated if reducing the dose of baricitinib (BCB; Olumiant) maintained low disease activity (LDA) in rheumatoid arthritis (RA). They found that a lower dose of BCB maintained LDA in some patients while the others could be rescued by switching to the original dose. 

This study wanted to find out if treating breast cancer with everolimus (Afintor) and endocrine therapy is better than only treating with endocrine therapy. The study found that using everolimus in addition to endocrine therapy had a significant benefit to survival in these patients.

This study wanted to find out how well lurbinectedin (PM01183) works in treatment of breast cancer with BRCA1/2 mutations (abnormal genes), which has spread. The study found that lurbinectedin worked well in treating patients with BRCA1/2 mutated breast cancer which had spread.

This study investigated if emotional health affects pain in patients with rheumatoid arthritis (RA). They found that emotional health, along with physical state can have an effect on pain in RA. 

This study reviewed information on the use of tofacitinib (Xeljanz) for the treatment of rheumatoid arthritis (RA). They found that tofacitinib is effective and well-tolerated for patients with RA.

This article investigated the safety and effectiveness of myofascial release (MR) therapy on women survivors of breast cancer. The authors concluded that MR therapy is safe and resulted in physical benefits (overall shoulder movement, functionality, pain). 

This study investigated if exercise and anti-TNF medication can improve cardiovascular health (CVH) in patients with rheumatoid arthritis (RA).

They found that combining exercise and anti-TNF medication improved CVH in these patients.

This paper was looking at which type of therapy is best for women with breast cancer who are experiencing major depression. The study found that all three therapies tested resulted in equal benefit for the patients.  

This study wanted to find out if adding a medication called olanzapine (Zyprexa) to the current treatment methods helps reduce vomiting and nausea in patients with breast cancer who are receiving chemotherapy with anthracycline. The study found that adding in olanzapine to standard treatment helped reduce vomiting and nausea compared to just using the standard treatment.

This study investigated if etanercept is effective at treating flare-ups in patients with rheumatoid arthritis.

They found that etanercept reduces disease activity following flare-ups in these patients.